Published in J Virol on March 21, 2007
Tegument proteins of human cytomegalovirus. Microbiol Mol Biol Rev (2008) 1.50
Viral and host control of cytomegalovirus maturation. Trends Microbiol (2012) 1.15
Human cytomegalovirus UL50 and UL53 recruit viral protein kinase UL97, not protein kinase C, for disruption of nuclear lamina and nuclear egress in infected cells. J Virol (2013) 1.03
Biochemical, biophysical, and mutational analyses of subunit interactions of the human cytomegalovirus nuclear egress complex. J Virol (2009) 1.01
Dominant negative mutants of the murine cytomegalovirus M53 gene block nuclear egress and inhibit capsid maturation. J Virol (2010) 1.01
High-throughput analysis of human cytomegalovirus genome diversity highlights the widespread occurrence of gene-disrupting mutations and pervasive recombination. J Virol (2015) 0.98
The m74 gene product of murine cytomegalovirus (MCMV) is a functional homolog of human CMV gO and determines the entry pathway of MCMV. J Virol (2010) 0.97
Herpes simplex virus 1 pUL34 plays a critical role in cell-to-cell spread of virus in addition to its role in virus replication. J Virol (2011) 0.93
Structure of a herpesvirus nuclear egress complex subunit reveals an interaction groove that is essential for viral replication. Proc Natl Acad Sci U S A (2015) 0.91
M94 is essential for the secondary envelopment of murine cytomegalovirus. J Virol (2011) 0.90
Mapping of sequences in Pseudorabies virus pUL34 that are required for formation and function of the nuclear egress complex. J Virol (2013) 0.89
Cytomegalovirus downregulates IRE1 to repress the unfolded protein response. PLoS Pathog (2013) 0.88
Human cytomegalovirus UL97 phosphorylates the viral nuclear egress complex. J Virol (2014) 0.85
A beta-herpesvirus with fluorescent capsids to study transport in living cells. PLoS One (2012) 0.84
Cytomegalovirus replicon-based regulation of gene expression in vitro and in vivo. PLoS Pathog (2012) 0.84
Characterization of conserved region 2-deficient mutants of the cytomegalovirus egress protein pM53. J Virol (2012) 0.84
Dominant-negative proteins in herpesviruses - from assigning gene function to intracellular immunization. Viruses (2009) 0.77
A modified screening system for loss-of-function and dominant negative alleles of essential MCMV genes. PLoS One (2014) 0.75
Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene (1995) 15.67
Functional inactivation of genes by dominant negative mutations. Nature (1987) 13.12
The protein network of HIV budding. Cell (2003) 7.82
Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci U S A (1997) 5.37
Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci U S A (2003) 5.21
Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol (1985) 4.76
Herpesviral protein networks and their interaction with the human proteome. Science (2005) 4.74
Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc Natl Acad Sci U S A (2003) 4.21
Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina. Science (2002) 4.13
Gene therapy. Intracellular immunization. Nature (1988) 3.60
U(L)31 and U(L)34 proteins of herpes simplex virus type 1 form a complex that accumulates at the nuclear rim and is required for envelopment of nucleocapsids. J Virol (2001) 3.56
Ultrastructural localization of the herpes simplex virus type 1 UL31, UL34, and US3 proteins suggests specific roles in primary envelopment and egress of nucleocapsids. J Virol (2002) 3.45
A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science (2001) 2.70
Rapid identification of essential and nonessential herpesvirus genes by direct transposon mutagenesis. Nat Biotechnol (1999) 2.61
Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol (2004) 2.43
Mutations in gag proteins P12 and P15 of Moloney murine leukemia virus block early stages of infection. J Virol (1984) 2.30
Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses. Nat Genet (2005) 2.19
A simple in vitro Tn7-based transposition system with low target site selectivity for genome and gene analysis. Nucleic Acids Res (2000) 2.12
Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J Virol (2003) 2.09
Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus. Nature (1988) 2.06
Freeze substitution of high-pressure frozen samples: the visibility of biological membranes is improved when the substitution medium contains water. J Microsc (2002) 1.98
The essential protein encoded by the UL31 gene of herpes simplex virus 1 depends for its stability on the presence of UL34 protein. Proc Natl Acad Sci U S A (2000) 1.89
Role of human cytomegalovirus UL131A in cell type-specific virus entry and release. J Gen Virol (2006) 1.83
Herpesvirus genetics has come of age. Trends Microbiol (2002) 1.66
Characterization and intracellular localization of the Epstein-Barr virus protein BFLF2: interactions with BFRF1 and with the nuclear lamina. J Virol (2005) 1.62
Comprehensive mutational analysis of a herpesvirus gene in the viral genome context reveals a region essential for virus replication. J Virol (2004) 1.59
BFRF1 of Epstein-Barr virus is essential for efficient primary viral envelopment and egress. J Virol (2005) 1.59
The Epstein-Barr virus BFRF1 and BFLF2 proteins interact and coexpression alters their cellular localization. Virology (2004) 1.54
Functional domains of murine cytomegalovirus nuclear egress protein M53/p38. J Virol (2006) 1.41
Late viral interference induced by transdominant Gag of an endogenous retrovirus. Proc Natl Acad Sci U S A (2004) 1.34
Common and specific properties of herpesvirus UL34/UL31 protein family members revealed by protein complementation assay. J Virol (2006) 1.34
Inhibition of herpes simplex virus type 1 DNA replication by mutant forms of the origin-binding protein. Virology (1993) 1.33
Focal adhesion kinase plays a pivotal role in herpes simplex virus entry. J Biol Chem (2005) 1.24
Conditional cytomegalovirus replication in vitro and in vivo. J Virol (2005) 1.03
Gene therapy progress and prospects: novel gene therapy approaches for AIDS. Gene Ther (2005) 0.96
Characterization of hepatitis B virus core mutants that inhibit viral replication. Virology (1994) 0.93
A novel tetracycline-inducible viral replication switch. Hum Gene Ther (1999) 0.86
Use of dominant negative mutants of the hepadnaviral core protein as antiviral agents. Hepatology (1996) 0.84
Inhibition of HIV/SIV replication by dominant negative Gag mutants. Virus Genes (1999) 0.81
Comparative study and identification of potent eukaryotic transcriptional repressors in gene switch systems. J Biotechnol (2002) 0.81
Nanotubular highways for intercellular organelle transport. Science (2004) 6.04
Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe (2009) 4.54
Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina. Science (2002) 4.13
High-resolution gene expression profiling for simultaneous kinetic parameter analysis of RNA synthesis and decay. RNA (2008) 3.13
Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol (2003) 3.02
MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat Immunol (2002) 2.66
Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol (2004) 2.43
Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J Exp Med (2002) 2.37
Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J Gen Virol (2008) 2.35
Conserved principles of mammalian transcriptional regulation revealed by RNA half-life. Nucleic Acids Res (2009) 2.26
Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J Virol (2003) 2.09
IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol (2005) 2.05
Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication. PLoS Pathog (2012) 2.04
Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog (2007) 1.93
The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host. Cell Host Microbe (2008) 1.92
Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe (2010) 1.91
Mouse cytomegalovirus microRNAs dominate the cellular small RNA profile during lytic infection and show features of posttranscriptional regulation. J Virol (2007) 1.90
Sphingosylphosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells. Nat Cell Biol (2003) 1.84
Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection. Cell Host Microbe (2011) 1.72
Herpesvirus genetics has come of age. Trends Microbiol (2002) 1.66
Viruses know it all: new insights into IFN networks. Trends Immunol (2005) 1.62
NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med (2005) 1.60
Comprehensive mutational analysis of a herpesvirus gene in the viral genome context reveals a region essential for virus replication. J Virol (2004) 1.59
Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo. PLoS Pathog (2008) 1.58
Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses. J Virol (2004) 1.55
Shedding light on the elusive role of endothelial cells in cytomegalovirus dissemination. PLoS Pathog (2011) 1.51
Biomaterials: silk-like secretion from tarantula feet. Nature (2006) 1.47
Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host. J Virol (2005) 1.46
Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J Exp Med (2009) 1.45
Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells. Macromol Biosci (2008) 1.44
Changing sexual behavior among gay male repeat testers for HIV: a randomized, controlled trial of a single-session intervention. J Acquir Immune Defic Syndr (2002) 1.44
Cloning of herpesviral genomes as bacterial artificial chromosomes. Rev Med Virol (2003) 1.43
Induction of cell polarization and migration by a gradient of nanoscale variations in adhesive ligand spacing. Nano Lett (2008) 1.43
UL74 of human cytomegalovirus contributes to virus release by promoting secondary envelopment of virions. J Virol (2008) 1.42
Functional domains of murine cytomegalovirus nuclear egress protein M53/p38. J Virol (2006) 1.41
Degradation of cellular mir-27 by a novel, highly abundant viral transcript is important for efficient virus replication in vivo. PLoS Pathog (2012) 1.40
HCMV spread and cell tropism are determined by distinct virus populations. PLoS Pathog (2011) 1.40
Fusion between phagosomes, early and late endosomes: a role for actin in fusion between late, but not early endocytic organelles. Mol Biol Cell (2003) 1.36
Cytomegalovirus primary envelopment occurs at large infoldings of the inner nuclear membrane. J Virol (2006) 1.34
Common and specific properties of herpesvirus UL34/UL31 protein family members revealed by protein complementation assay. J Virol (2006) 1.34
Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. Biomaterials (2006) 1.30
A capsid-encoded PPxY-motif facilitates adenovirus entry. PLoS Pathog (2010) 1.29
Dendritic cells under influence of mouse cytomegalovirus have a physiologic dual role: to initiate and to restrict T cell activation. J Infect Dis (2003) 1.28
Brief cognitive counseling with HIV testing to reduce sexual risk among men who have sex with men: results from a randomized controlled trial using paraprofessional counselors. J Acquir Immune Defic Syndr (2007) 1.27
The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J Exp Med (2006) 1.27
Ignicoccus hospitalis and Nanoarchaeum equitans: ultrastructure, cell-cell interaction, and 3D reconstruction from serial sections of freeze-substituted cells and by electron cryotomography. Arch Microbiol (2008) 1.26
Impairment of nuclear pores in bovine herpesvirus 1-infected MDBK cells. J Virol (2005) 1.25
Ultrashort and progressive 4sU-tagging reveals key characteristics of RNA processing at nucleotide resolution. Genome Res (2012) 1.24
Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J Virol (2005) 1.21
Virus progeny of murine cytomegalovirus bacterial artificial chromosome pSM3fr show reduced growth in salivary Glands due to a fixed mutation of MCK-2. J Virol (2011) 1.20
Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell response. J Immunol (2004) 1.20
Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception. J Virol (2005) 1.15
Coordinated function of murine cytomegalovirus genes completely inhibits CTL lysis. J Immunol (2006) 1.14
Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses. Nat Nanotechnol (2013) 1.12
Major tegument protein pp65 of human cytomegalovirus is required for the incorporation of pUL69 and pUL97 into the virus particle and for viral growth in macrophages. J Virol (2008) 1.12
Mutagenesis of viral BACs with linear PCR fragments (ET recombination). Methods Mol Biol (2004) 1.10
Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents. Mol Imaging Biol (2008) 1.10
FoxO3 induces reversible cardiac atrophy and autophagy in a transgenic mouse model. Cardiovasc Res (2011) 1.09
The effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophages. Biomaterials (2010) 1.08
Decellularized cartilage matrix as a novel biomatrix for cartilage tissue-engineering applications. Tissue Eng Part A (2012) 1.08
Determinants of endocytic membrane geometry, stability, and scission. Proc Natl Acad Sci U S A (2011) 1.08
Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene. J Virol (2007) 1.07
SH4-domain-induced plasma membrane dynamization promotes bleb-associated cell motility. J Cell Sci (2007) 1.07
Protein pUL128 of human cytomegalovirus is necessary for monocyte infection and blocking of migration. J Virol (2011) 1.07
Genetic reconstitution of the human adenovirus type 2 temperature-sensitive 1 mutant defective in endosomal escape. Virol J (2009) 1.07
Transcriptional activation of the adenoviral genome is mediated by capsid protein VI. PLoS Pathog (2012) 1.06
Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells. PLoS One (2011) 1.06
"Tips and tricks" for high-pressure freezing of model systems. Methods Cell Biol (2010) 1.05
The nucleotide sequence and a first generation gene transfer vector of species B human adenovirus serotype 3. Virology (2005) 1.05
Maturation of the 5S rRNA 5' end is catalyzed in vitro by the endonuclease tRNase Z in the archaeon H. volcanii. RNA (2008) 1.04
Viral interference with B7-1 costimulation: a new role for murine cytomegalovirus fc receptor-1. J Immunol (2006) 1.04
The human cytomegalovirus UL45 gene product is a late, virion-associated protein and influences virus growth at low multiplicities of infection. J Gen Virol (2003) 1.04
Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1. J Immunol (2010) 1.03
The tegument protein UL71 of human cytomegalovirus is involved in late envelopment and affects multivesicular bodies. J Virol (2011) 1.03
Cytomegalovirus microRNAs facilitate persistent virus infection in salivary glands. PLoS Pathog (2010) 1.03
Conditional cytomegalovirus replication in vitro and in vivo. J Virol (2005) 1.03
Dominant negative mutants of the murine cytomegalovirus M53 gene block nuclear egress and inhibit capsid maturation. J Virol (2010) 1.01